Belgium
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 37.77 B |
Jan. 14, 2025 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 6.87 B |
Jan. 14, 2025 | USD 150.68 | -0.48% |
|
Belgium |
|
3 |
USD 4.69 B |
Jan. 14, 2025 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
USD 1.68 B |
Jan. 14, 2025 | USD 24.20 | -0.41% |
|
Belgium |
|
5 |
USD 1.27 B |
Jan. 14, 2025 | USD 17.21 | 1.09% |
|
Belgium |
|
6 |
USD 402.37 M |
Jan. 14, 2025 | USD 13.71 | -0.44% |
|
Belgium |
|
7 |
USD 348.82 M |
Jan. 14, 2025 | USD 9.32 | -0.11% |
|
Belgium |
|
8 |
USD 174.30 M |
Jan. 14, 2025 | USD 6.22 | -0.06% |
|
Belgium |
|
9 |
USD 139.62 M |
Jan. 14, 2025 | USD 2.81 | 6.87% |
|
Belgium |
|
10 |
USD 98.99 M |
Jan. 14, 2025 | USD 2.00 | NA |
|
Belgium |
The Pharmaceuticals company in Belgium with the highest Market Capitalization is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 37.77 B.
The Pharmaceuticals company in Belgium with the lowest Market Capitalization is MDxHealth SA (NasdaqCM: MDXH) at USD 98.99 M.
The top 10 Pharmaceuticals companies in Belgium by Market Capitalization are UCB SA, Financière de Tubize SA, Azelis Group NV, Galapagos NV, Fagron NV, Ion Beam Applications SA, Nyxoah S.A., Hyloris Pharmaceuticals SA, Sequana Medical NV and MDxHealth SA.
The bottom 10 Pharmaceuticals companies in Belgium by Market Capitalization are MDxHealth SA, Sequana Medical NV, Hyloris Pharmaceuticals SA, Nyxoah S.A., Ion Beam Applications SA, Fagron NV, Galapagos NV, Azelis Group NV, Financière de Tubize SA and UCB SA.